Journal list Promote Sponsor
verified SJR 0,474 · Q3 • database Scopus / SJR & Web of Science indexed
Future Cardiology
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q3 — Molecular Medicine lock Subscription

Future Cardiology

Future Cardiology is a journal indexed in SJR in Molecular Medicine and Cardiology and Cardiovascular Medicine with an H index of 45. It has an SJR impact factor of 0,474 and it has a best quartile of Q3. It has an SJR impact factor of 0,474.

ISSN: 1479-6678
Publisher: Taylor and Francis Ltd.
Category: Molecular Medicine
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,474 Q3
H-index 45
Acceptance rate pie_chart
34%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,474

H-index

45

Docs (year)

98

Docs 3y

325

Total refs

3393

Cites 3y

431

Citable 3y

308

Cites/Doc 2y

1.09

Ref/Doc

34.62

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Atrial fibrillation in the elderly: a review

View more

WIRION‚Ñ¢ embolic protection system for carotid artery stenting and lower extremity endovascular intervention

View more

Cardiovascular magnetic resonance in ischemic heart disease

View more

Cardiotoxicity in childhood cancer survivors: strategies for prevention and management

View more

Cardiomyocyte transverse tubule loss leads the way to heart failure

View more

Bosentan for the treatment of adult pulmonary hypertension

View more

Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox

View more

Blood pressure target goals from guidelines of 2002-2014

View more

Beyond blood pressure: pulse wave analysis -a better way of assessing cardiovascular risk?

View more

beta-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease

View more

Benefits of an integrated heart failure service at critical periods in the heart failure disease trajectory

View more

Beating-heart valve surgery: is the introduction of lung perfusion/ventilation the next step?

View more
SHOW MORE ARTICLES

Beating heart continuous coronary perfusion for valve surgery: what next for clinical trials?

View more

3D echocardiography in congenital heart disease: a valuable tool for the surgeon

View more

ATLANTIC and beyond: an interview with Professor Azfar Zaman

View more

Assessment of cardiac dynamics during stress echocardiography by the peak power output-to-left ventricular mass ratio

View more

Aortic valve disease: preventable or inevitable?

View more

Anemia in heart failure: an overview of current concepts

View more

After FRANCIS: next steps in the clinical evaluation of varespladib methyl

View more

Advances in the field of interventional cardiology: spotlight on transcatheter aortic valve implantation

View more

Advances in interventional neuroradiology: novel use of mechanical thrombectomy in acute ischemic stroke

View more

Advances in heart failure surgery

View more

Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia

View more

A systematic review and meta-analysis evaluating ischemic conditioning during percutaneous coronary intervention

View more

FAQs